Trials / Unknown
UnknownNCT03431454
Comparison of Three Vision Therapy Approaches for Convergence Insufficiency
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Shahid Beheshti University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 15 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
We compared the effectiveness of three active vision therapy approaches for convergence insufficiency (CI). Patients with eligible criteria and symptomatic CI were included in a prospective study and randomly allocated into three groups. In the home-based vision orthoptic therapy (HBVOT) group, patients were trained to do the pencil push-ups procedure 15 minutes per day, five days a week. In the office-based vision orthoptic therapy (OBVOT) group, 60 minutes of orthoptic therapy using a major amblyoscope twice weekly with additional home orthoptic therapy was prescribed. For the augmented office-based vision orthoptic therapy (AOBVOT) group, orthoptic exercises using three diopter over-minus lenses and a base out prism, in addition to major amblyoscope and additional home reinforcement was prescribed in the same period of time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | trained to do the pencil push-ups procedure | 15 minutes per day, five days a week |
| PROCEDURE | using a major amblyoscope twice weekly with additional home orthoptic therapy | 60 minutes of orthoptic therapy using a major amblyoscope twice weekly with additional home orthoptic therapy was prescribed. |
| PROCEDURE | using three diopter over-minus lenses and a base out prism | For the augmented office-based vision orthoptic therapy (AOBVOT) group, orthoptic exercises using three diopter over-minus lenses and a base out prism, in addition to major amblyoscope and additional home reinforcement was prescribed in the same period of time. |
Timeline
- Start date
- 2018-02-01
- Primary completion
- 2018-07-01
- Completion
- 2018-12-01
- First posted
- 2018-02-13
- Last updated
- 2018-02-13
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT03431454. Inclusion in this directory is not an endorsement.